Lo/Ovral Contraceptive: Uses, Dosage & Side Effects
Table of Contents
Introduction
Lo/Ovral is a combination hormonal contraceptive pill containing norgestrel and ethinyl estradiol. It is used primarily for preventing pregnancy in women of reproductive age. Lo/Ovral works by suppressing ovulation and thickening cervical mucus, creating a barrier to sperm.
Chemical Composition
Lo/Ovral contains two active compounds:
- Norgestrel (0.3 mg) – A Norgestrel“>synthetic progestin
- Ethinyl Estradiol (0.03 mg) – A synthetic estrogen derivative
Usage
Lo/Ovral is primarily used as an oral contraceptive to prevent pregnancy. It may also be prescribed for off-label uses such as regulating menstrual cycles or managing endometriosis symptoms.
Dosage Information
Lo/Ovral is typically taken daily for 21 days, followed by a 7-day hormone-free interval. If a dose is missed, refer to the patient information leaflet or consult a healthcare provider for guidance.
Administration
Lo/Ovral tablets are taken orally, typically at the same time each day. The pill pack is designed with daily markers to aid in adherence to the dosage schedule.
Side Effects
Common side effects of Lo/Ovral may include:
Serious side effects are rare but can include blood clots, stroke, or heart attack. Seek immediate medical attention if severe side effects occur.
Interactions
Lo/Ovral may interact with certain medications, including antibiotics, anti-seizure drugs, and HIV medications. Always inform your healthcare provider about all medicines you are taking.
Contraindications
Lo/Ovral should not be used by women who have a history of blood clots, stroke, heart attack, or certain types of cancer. It is also contraindicated in women over 35 who smoke.
Warnings and Precautions
Lo/Ovral may increase the risk of serious cardiovascular events, especially in women with risk factors such as smoking, obesity, or diabetes. Regular check-ups with a healthcare provider are recommended.
Efficacy
When taken correctly, Lo/Ovral is highly effective in preventing pregnancy. Studies show that combination oral contraceptives like Lo/Ovral have a typical use failure rate of about 7%.
Patient Information
Patients should be counseled on the proper use of Lo/Ovral, potential side effects, and the importance of regular follow-up with a healthcare provider. Missed pill guidelines should be clearly explained.
Packaging Details
Lo/Ovral is packaged in a monthly pill dispenser with a pink carrying sleeve. The sleeve features an embossed perimeter and a decorative floral and butterfly design.
Regulatory Status
Lo/Ovral is an FDA-approved prescription medication. It was first approved for use in the United States in 1973.
Comparisons with Other Oral Contraceptives
Lo/Ovral contains a lower dose of hormones compared to some older oral contraceptives. It is similar in composition to other low-dose pills like Cryselle and Lo/Ovral-28.
Clinical Studies and Research
Numerous clinical studies have been conducted to evaluate the efficacy, safety, and side effect profile of Lo/Ovral and similar combination oral contraceptives. Research continues to assess long-term effects and potential non-contraceptive benefits.
